These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27272291)

  • 1. RhD immune globulin: over 50 years of remarkable progress!
    Silver RM
    BJOG; 2016 Jul; 123(8):1347. PubMed ID: 27272291
    [No Abstract]   [Full Text] [Related]  

  • 2. Thirty-five years of Rh prophylaxis.
    Bowman J
    Transfusion; 2003 Dec; 43(12):1661-6. PubMed ID: 14641860
    [No Abstract]   [Full Text] [Related]  

  • 3. William W. Pollack, PhD: a pioneer in perinatology.
    Moise KJ
    Obstet Gynecol; 2014 Mar; 123(3):493-494. PubMed ID: 24499768
    [No Abstract]   [Full Text] [Related]  

  • 4. Fifty years of RhD immunoglobulin (anti-D) therapy in Australia: celebrating a public health success story.
    Thyer J; Wong J; Thomson A; Bell B; Hyland C; Challis D
    Med J Aust; 2018 Oct; 209(8):336-339. PubMed ID: 30309307
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of isoimmunization in pregnancy developed by Freda and Gorman.
    Dunn LJ
    Obstet Gynecol Surv; 1999 Dec; 54(12 Suppl):S1-6. PubMed ID: 10603603
    [No Abstract]   [Full Text] [Related]  

  • 6. The history of rhesus prophylaxis with anti-D.
    Wegmann A; Glück R
    Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidance on anti-D administration in early pregnancy.
    Dempsey A; Overton C
    BJOG; 2013 Dec; 120(13):1696. PubMed ID: 24588996
    [No Abstract]   [Full Text] [Related]  

  • 8. Authors' reply: guidance on anti-D administration in early pregnancy.
    Bolton-Maggs P; Davies T; Poles D; Cohen H
    BJOG; 2013 Dec; 120(13):1696-7. PubMed ID: 24588997
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing RhD haemolytic disease of the newborn. New recommendations must be explained to GPs and midwives.
    Everett C; Wray J
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569419
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing RhD haemolytic disease of the newborn. Guidelines are not followed in many cases.
    McFadyen IR; Martlew VJ; Howard HL; Clarke CA
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569417
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rhesus prophylaxis--history and current status].
    Behrens O; Lellé RJ
    Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-D guidelines.
    Kanjilal K; Tasker M
    Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-D immunoglobulin in RhD prophylaxis.
    Robson SC; Lee D; Urbaniak S
    Br J Obstet Gynaecol; 1998 Feb; 105(2):129-34. PubMed ID: 9501773
    [No Abstract]   [Full Text] [Related]  

  • 15. Preventing RhD haemolytic disease of the newborn.
    van Dijk B
    BMJ; 1997 Dec; 315(7121):1480-1. PubMed ID: 9420481
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing RhD haemolytic disease of the newborn. Women should be counselled about source of anti-D immunoglobulin.
    Saha A
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569418
    [No Abstract]   [Full Text] [Related]  

  • 17. Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme.
    Mayne S; Parker JH; Harden TA; Dodds SD; Beale JA
    BMJ; 1997 Dec; 315(7122):1588. PubMed ID: 9437277
    [No Abstract]   [Full Text] [Related]  

  • 18. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous rho (D) immune globulin.
    Sandler SG
    Transfus Med Rev; 2001 Jan; 15(1):67-76. PubMed ID: 11149979
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-D administration in early pregnancy--time for a new protocol.
    Carmody F
    Aust N Z J Obstet Gynaecol; 1996 May; 36(2):227-8. PubMed ID: 8798328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.